Corcept Therapeutics's market cap is currently $6.29B. The company's EPS TTM is $1.257; its P/E ratio is 47.71; Corcept Therapeutics is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $0.38. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 482.38M	$ 401.86M	$ 365.98M	$ 353.87M	$ 306.49M
Gross Profit	$ 475.89M	$ 396.47M	$ 360.70M	$ 348.29M	$ 300.98M
Operating Income	$ 107.28M	$ 112.63M	$ 124.48M	$ 128.20M	$ 111.61M
EBITDA	$ 108.32M	$ 112.63M	$ 124.48M	$ 130.44M	$ 113.78M
Net Income	$ 106.14M	$ 101.42M	$ 112.51M	$ 106.01M	$ 94.18M
Balance Sheet
Cash & Short-Term Investments	$ 368.22M	$ 436.62M	$ 335.81M	$ 476.89M	$ 315.31M
Total Assets	$ 621.52M	$ 583.43M	$ 423.76M	$ 571.73M	$ 412.31M
Total Debt	$ 151.00K	$ 1.14M	$ 526.00K	$ 2.55M	$ 3.46M
Net Debt	$ -135.40M	$ -435.48M	$ -335.29M	$ -474.34M	$ -311.85M
Total Liabilities	$ 114.81M	$ 81.59M	$ 47.95M	$ 48.39M	$ 41.13M
Stockholders' Equity	$ 506.70M	$ 501.84M	$ 375.81M	$ 523.34M	$ 371.18M
Cash Flow
Free Cash Flow	$ 126.90M	$ 119.91M	$ 167.42M	$ 150.73M	$ 135.03M
Operating Cash Flow	$ 127.04M	$ 120.32M	$ 167.89M	$ 151.97M	$ 136.12M
Investing Cash Flow	$ 90.91M	$ -114.33M	$ 136.13M	$ -119.26M	$ -117.83M
Financing Cash Flow	$ -148.72M	$ -17.28M	$ -302.59M	$ 12.21M	$ -28.64M

Currency in USD

Corcept Therapeutics Earnings and Revenue History

Income Statement >

Corcept Therapeutics Debt to Assets

Balance Sheet >

Corcept Therapeutics Cash Flow

Cash Flow >

Corcept Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing